Biotech - Spark Newswire

2 minute read

Biomerica Receives Notice Of Allowance From Mexican Patent Office For Irritable Bowel Syndrome Food Sensitivity Testing & Treatment

Today, 4:05 AM

Biomerica, Inc. (NASDAQ:BMRA) today announced that the Mexican Patent Office has issued a notice of allowance for Biomerica's patent application pertaining to the Company's InFoods® technology platform

BMRA

1 minute read

Why Sage Therapeutics (SAGE) Stock Is Falling Despite Meeting Primary Endpoint In Major Depressive Disorder Trial With Zuranolone

By Vandana Singh

Today, 4:05 AM

Looking to make a comeback after a big Phase 3 flop, Sage Therapeutics Inc (NASDAQ:SAGE) revealed data from another Phase 3…

BIIB

6 minute read

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

By Shanthi Rexaline

Today, 4:05 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)

ACHL

1 minute read

CRISPR Therapeutics, Capsida Collaborate To Develop Gene-Edited Therapies For Neurological Diseases

By Vandana Singh

Today, 4:05 AM

CRISPR Therapeutics (NASDAQ:CRSP) has signed a deal with Capsida Biotherapeutics, a gene therapy player specializing in AAV engineering, to carve out a…

CRSP

1 minute read

Cytokinetics Announces Completion Of Enrollment In METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure With Reduced Ejection Fraction

By Bill Haddad

Today, 4:05 AM

Cytokinetics, Incorporated (NASDAQ:CYTK) today announced the completion of patient enrollment in METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related

CYTK

1 minute read

Ocugen Announces Jubilant HollisterStier As Manufacturing Partner For US Production Of COVID-19 Vaccine Candidate, COVAXIN

By Bill Haddad

Today, 4:05 AM

Ocugen, Inc. (NASDAQ:OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19,

OCGN

1 minute read

Clearside Biomedical Shares Soar On Encouraging Safety Profile For Injectable Axitinib In Wet AMD Patients

By Vandana Singh

Today, 4:05 AM

Clearside Biomedical Inc (NASDAQ:CLSD) has announced positive safety results from Cohort 1 (n=6) of OASIS Phase 1/2a trial of CLS-AX (axitinib…

CLSD

1 minute read

Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors

By Vandana Singh

Today, 4:05 AM

Cellectis SA (NASDAQ:CLLS) has announced four new preclinical UCART product candidates targeting solid tumors – UCART20x22; the first allogeneic bi-specific CAR-T…

CLLS

1 minute read

Fusion Pharma’s Stock Moves Higher As Radiopharmaceutical Candidate Shows Early Promising Action In Solid Tumor Study

By Vandana Singh

Today, 4:05 AM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) has announced preliminary Phase 1 data from the single-dose portion of the study evaluating FPI-1434 in patients…

AZN

1 minute read

Cerevel Therapeutics Announces Fast Track Designation Granted By The FDA To CVL-871 For The Treatment Of Dementia-Related Apathy

By Bill Haddad

Today, 4:05 AM

Cerevel Therapeutics (NASDAQ:CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that the U.S. Food and Drug Administration (FDA) has granted

CERE